Covered recipient · General Payments record
JENNIFER K SAFFELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$867.28
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.63 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $195.61 | 8 |
| Braeburn Inc. | $162.25 | 11 |
| Regeneron Healthcare Solutions, Inc. | $36.43 | 2 |
| Hikma Pharmaceuticals USA | $33.12 | 2 |
| Gilead Sciences, Inc. | $25.00 | 1 |
| Orexo US, Inc. | $21.88 | 1 |
| OptiNose US, Inc. | $17.66 | 1 |
| ABBVIE INC. | $17.39 | 1 |
| GENZYME CORPORATION | $15.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.39 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108132842 | CMS |
| Braeburn Inc. | $13.08 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615041 | CMS |
| Braeburn Inc. | $12.49 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615029 | CMS |
| Braeburn Inc. | $20.55 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615035 | CMS |
| Braeburn Inc. | $13.67 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615039 | CMS |
| Braeburn Inc. | $16.71 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615037 | CMS |
| Braeburn Inc. | $8.73 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615033 | CMS |
| Braeburn Inc. | $19.02 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615031 | CMS |
| Braeburn Inc. | $15.54 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615045 | CMS |
| Braeburn Inc. | $17.72 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615043 | CMS |
| Braeburn Inc. | $10.92 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615049 | CMS |
| Braeburn Inc. | $13.82 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615047 | CMS |
| GENZYME CORPORATION | $15.29 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139748254 | CMS |
| Gilead Sciences, Inc. | $25.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133651088 | CMS |
| Hikma Pharmaceuticals USA | $14.71 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127503197 | CMS |
| Hikma Pharmaceuticals USA | $18.41 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127503249 | CMS |
| Indivior Inc. | $37.47 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569782 | CMS |
| Indivior Inc. | $16.10 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569784 | CMS |
| Indivior Inc. | $45.68 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569786 | CMS |
| Indivior Inc. | $24.81 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569788 | CMS |
| Indivior Inc. | $26.77 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569790 | CMS |
| Indivior Inc. | $22.88 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569792 | CMS |
| Indivior Inc. | $3.89 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569794 | CMS |
| Indivior Inc. | $18.01 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144569796 | CMS |
| Optinose US, Inc. | $17.66 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142174784 | CMS |
| Orexo US, Inc. | $21.88 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136178350 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.35 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114366486 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.08 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114366488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.